241 related articles for article (PubMed ID: 12225445)
1. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?
Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
Aust N Z J Psychiatry; 2002 Oct; 36(5):622-8. PubMed ID: 12225445
[TBL] [Abstract][Full Text] [Related]
2. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
3. Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome.
Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
Aust N Z J Psychiatry; 2001 Aug; 35(4):443-8. PubMed ID: 11531723
[TBL] [Abstract][Full Text] [Related]
4. Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?
Feeney GF; Connor JP; McD Young R; Tucker J; McPherson A
J Addict Dis; 2006; 25(4):49-58. PubMed ID: 17088225
[TBL] [Abstract][Full Text] [Related]
5. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
6. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.
Donovan DM; Anton RF; Miller WR; Longabaugh R; Hosking JD; Youngblood M;
J Stud Alcohol Drugs; 2008 Jan; 69(1):5-13. PubMed ID: 18080059
[TBL] [Abstract][Full Text] [Related]
7. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
8. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?
De Wildt WA; Schippers GM; Van Den Brink W; Potgieter AS; Deckers F; Bets D
Alcohol Alcohol; 2002; 37(4):375-82. PubMed ID: 12107041
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.
Baltieri DA; de Andrade AG
Braz J Psychiatry; 2003 Sep; 25(3):156-9. PubMed ID: 12975689
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
12. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
[TBL] [Abstract][Full Text] [Related]
13. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.
Weiss RD; O'malley SS; Hosking JD; Locastro JS; Swift R;
J Stud Alcohol Drugs; 2008 Nov; 69(6):878-84. PubMed ID: 18925346
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
15. Acamprosate in the treatment of alcohol dependence.
Mason BJ
Expert Opin Pharmacother; 2005 Oct; 6(12):2103-15. PubMed ID: 16197362
[TBL] [Abstract][Full Text] [Related]
16. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
17. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.
Chick J; Howlett H; Morgan MY; Ritson B
Alcohol Alcohol; 2000; 35(2):176-87. PubMed ID: 10787394
[TBL] [Abstract][Full Text] [Related]
18. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
Poldrugo F
Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial.
Reid SC; Teesson M; Sannibale C; Matsuda M; Haber PS
J Stud Alcohol; 2005 Nov; 66(6):833-41. PubMed ID: 16459945
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
